Prescribing privileges for clinical psychologists

References

• Akiskal H., McKinney W. Depressive disorders: toward a unified hypothesis. Science 1973; 182: 20–29
   PubMed Web of Science ®Google Scholar
• Azrin N. H., Sissons R. W., Meyer S. R., et al. Alcoholism treatment by disulfiram and community reinforcement approach to alcoholism. Journal of Behaviour Therapy and Experimental Psychiatry 1982; 13: 105–112
   PubMed Web of Science ®Google Scholar
• Bascue L. O., Zlotowski M. Psychologists' attitudes about prescribing medications. Psychological Reports 1981; 48: 645–646
   PubMedGoogle Scholar
• Birtchnell J. Recruitment into Psychiatry. SCP Report No 14. British Journal of Clinical and Social Psychiatry 1987; 5: 1–22
   Google Scholar
• Blackburn I. M., Bishop S., Glen I. M., Whalley L. J., Christie J. E. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. British Journal of Psychiatry 1981; 139: 181–189
   PubMed Web of Science ®Google Scholar
• Board of Professional Affairs Task Force Report (BPA). Psychologists' Use of Physical Interventions. American Psychological Association, Washington, DC 1981
   Google Scholar
• Brewer C. Combining Pharmacological Antagonists and Behavioural Psychotherapy in Treating Addictions: Why it is Effective but Unpopular. British Journal of Psychiatry 1990; 157: 34–40
   PubMed Web of Science ®Google Scholar
• British Psychological Society. Code of Conduct Ethical Principles and Guidelines. BPS, London 1991
   Google Scholar
• Curran H. V. Tranquillising memories: A review of the effects of benzodiazepines on human memory. Biological Psychology 1986; 23: 179–213
   PubMed Web of Science ®Google Scholar
• Dawley H., Jnr. Task Force Report on Professional Privileges for Psychologists. VA Practitioner 1991; 45–50
   Google Scholar
• DeLeon P. H. Psychoactive Medications: The Debate Reaches Hawaii's Legislature. Register Report 1990; 16: 9
   Google Scholar
• DeLeon P. H. Increasing the Societal Contribution of Organized Psychology. American Psychologist 1986; 41: 466–474
   PubMedGoogle Scholar
• DeLeon P. H., Fox R. E., Graham S. R. Prescription Privileges Psychology's Next Frontier?. American Psychologist 1991; 46: 384–393
   PubMed Web of Science ®Google Scholar
• Fox R. E. Prescription privileges: their implications for the practice of psychology. Psychotherapy 1988; 25: 501–507
   Web of Science ®Google Scholar
• General Dental Council. Recommendations concerning the Dental Curriculum. General Dental Council, London 1990
   Google Scholar
• Gray J. A. Interactions between drugs and behaviour therapy. Theoretical Foundations of Behaviour Therapy, H. J. Eysenck, I. Martin. Plenum, New York 1987
   Google Scholar
• Hayward P., Wardle J., Higgitt A. Benzodiazepine research: current findings and practical consequences. British Journal of Clinical Psychology 1989; 28: 307–327
   PubMedGoogle Scholar
• Hemsley D. R. The treatment of Schizophrenia. Handbook of Adult Clinical Psychology, S. Lindsay, G. Powell. Gower, Guildford 1987
   Google Scholar
• Hirsch S. R. Clinical Treatment of Schizophrenia. The Psychopharmacology and treatment of Schizophrenia, P. B. Bradley, S. R. Hirsch. Oxford University Press, Oxford 1986
   Google Scholar
• Jarvis M. J. Helping smokers give up. The Practice of Behavioural Medicine, S. Pearce, J. Wardle. Oxford University Press, Oxford 1989; 285–307
   Google Scholar
• Jarvis M. J., Raw M., Russell M. A. H., Feyerabend C. Randomised controlled trial of nicotine chewing-gum. British Medical Journal 1982; 285: 537–540
   PubMed Web of Science ®Google Scholar
• Jones B. J., Costall B., Domeney A. M., Kelly M. E., Naylor R. J., Oakley N. R., Tyers M. B. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist. British Journal of Pharmacology 1988; 93: 985–993
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Michelson L., Dealy R. S. Pharmacological treatment of agoraphobia: imipramine vs imipramine with programmed practice. British Journal of Psychiatry 1983; 143: 348–355
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Michelson L. Relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine treatment of agoraphobia. American Journal of Psychiatry 1986; 143: 1106–1112
   PubMed Web of Science ®Google Scholar
• Ossetin J. Methods and problems in the assessment of cognitive functions in epileptic patients. Epilepsy, Behaviour and Cognitive Function, M. R. Trimble, E. H. Reynolds. J Wiley, Chichester 1988
   Google Scholar
• Overton D. A. State-dependent learning produced by depressant and atropine-like drugs. Psychopharmacologia (Berlin) 1966; 12: 6–31
   Google Scholar
• Parraga H. C., Simonds J. F., Butterfield P. T. latrogenic behavioural and psychiatric symptoms in children with partial complex seizures. Journal of Developmental and Behavioral Paediatrics 1982; 3: 25–28
   PubMedGoogle Scholar
• Piotrowski C., Lubin B. Prescription privileges: a view from health psychologists. The Clinical Psychologist 1989; 42: 83–84
   Google Scholar
• Royal Pharmaceutical Society. Proposals on Nurse Prescribing. The Pharmaceutical Journal 1990; 17: 204
   Google Scholar
• State of California. Office of Statewide Health Planning and Development, Division of Health Professions Development. Health manpower prescribing and dispensing, pilot projects: Final report. California, Sacramento 1982
   Google Scholar
• Stitzer M. L., Bickel W. K., Bigelow G. E., Liebson I. A. Effects of Methadone Dose Contingencies on Urinalysis Test Results of Polydrug-Abusing Methadone-Maintenance Patients. Drug and Alcohol Dependence 1986; 18: 341–348
   PubMed Web of Science ®Google Scholar
• Swanson J. M., Kinsbourne M. Stimulantrelated state-dependent learning in hyperactive children. Science 1976; 192: 1354–1357
   PubMed Web of Science ®Google Scholar
• Taylor E., Schachar R. Clinical assessment and management strategies. The Overactive Child, E. Taylor. MacKeith Press/ Blackwell, London 1986
   Google Scholar
• Thompson P. J., Trimble M. R. Anticonvulsant drugs, cognitive functions. Epilepsia 1982; 23: 531–544
   PubMed Web of Science ®Google Scholar
• Torrey E. F., Erdman K., Wolfe S. M., Flynn L. M. Care of the Seriously Mentally III—A Rating of State Programs. Public Citizen Health Research Group and National Alliance for the Mentally III, Washington, DC 1990
   Google Scholar
• Trethowan W. H. The Role of Psychologists in the Health Services. Report of the Sub Committee, DHSS. 1974
   Google Scholar
• Wardle J. Behaviour therapy and benzodiazepines: Allies or antagonists. British Journal of Psychiatry 1990; 156: 163–168
   PubMed Web of Science ®Google Scholar
• Wardle J. Integrating psychology and pharmacology in the management of anxiety: a reply to ‘Psychology and pharmacology in the treatment of anxiety disorders’. Journal of Psychopharmacology 1991; 5: 293–295
   PubMedGoogle Scholar
• Woods R. L., Eames P. Application of behaviour modification in the treatment of traumatically brain-injured adults. Application of Conditioning Theory, G. Davey. Methuen, London 1981
   Google Scholar
• Youngstrom N. Membership poll supports Prescribing. APA Monitor 1991a; 22: 20–21
   Google Scholar
• Youngstrom N. Most child clinicians support prescribing. APA Monitor 1991b; 22: 21
   Google Scholar
• Zitrin C. M., Klein D. F., Woerner M. G. Treatment of phobias-1. Comparison of imipramine hydrochloride and placebo. Archives of General Psychiatry 1983; 40: 125–138
   PubMed Web of Science ®Google Scholar